Tower Research Capital LLC (TRC) - ALLOVIR INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ALLOVIR INC
ValueSharesWeighting
Q3 2023$13,736
-53.7%
6,389
-26.7%
0.00%
-100.0%
Q2 2023$29,655
+370587.5%
8,722
+315.9%
0.00%
Q1 2023$8
-79.5%
2,097
-72.7%
0.00%
-100.0%
Q4 2022$39
-99.8%
7,679
+158.4%
0.00%
Q3 2022$23,000
-11.5%
2,972
-54.9%
0.00%
-100.0%
Q2 2022$26,000
-29.7%
6,586
+20.7%
0.00%
Q1 2022$37,000
-7.5%
5,455
+77.9%
0.00%
-100.0%
Q4 2021$40,000
-36.5%
3,067
+22.8%
0.00%
-50.0%
Q3 2021$63,000
+46.5%
2,497
+14.3%
0.00%
+100.0%
Q2 2021$43,000
+13.2%
2,185
+32.8%
0.00%0.0%
Q1 2021$38,000
-83.0%
1,645
-71.7%
0.00%
-85.7%
Q4 2020$223,000
+120.8%
5,807
+58.3%
0.01%
+600.0%
Q3 2020$101,0003,6680.00%
Other shareholders
ALLOVIR INC shareholders Q4 2023
NameSharesValueWeighting ↓
Artal Group S.A. 2,323,371$89,310,0001.92%
Redmile Group, LLC 2,325,595$89,396,0001.08%
Woodline Partners LP 1,039,880$39,973,0001.06%
EcoR1 Capital, LLC 447,012$17,183,0000.92%
Samsara BioCapital, LLC 82,336$3,165,0000.32%
CNA FINANCIAL CORP 11,285$434,0000.14%
AMERICAN INTERNATIONAL GROUP, INC. 910,419$34,997,0000.13%
Virtus ETF Advisers LLC 7,339$282,0000.12%
Maven Securities LTD 19,901$799,0000.08%
TCW GROUP INC 216,135$8,308,0000.07%
View complete list of ALLOVIR INC shareholders